This is Noxopharm Limited
A company aiming to create a drug to treat cancer in an innovative way that we believe will bring significant change to the management of cancer.
Latest News
More News

CEO Blog

View more

ASX
Share Price Chart

Market Cap:
Price Delayed by ~20min

*market cap above based on the number of quoted shares (i.e. non-escrow stock)

Investor Information

ASX Announcements

read more

Features


March 2019 Corporate Presentation


FNN - Shaw & Partners Investor Event 26.2.19


Upcoming Events

AusBiotech Asian Investment Series Hong Kong and Shanghai, China March 26, 28-29 2019


READ MORE